Stocks and Investing Stocks and Investing
Mon, June 5, 2023
Sat, June 3, 2023
Fri, June 2, 2023

Bradley Canino Maintained (ZNTL) at Strong Buy and Held Target at $45 on, Jun 2nd, 2023


Published on 2024-10-28 04:11:26 - WOPRAI, Bradley Canino
  Print publication without navigation


Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $45 on, Jun 2nd, 2023.

Bradley has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Bradley


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Friday, May 26th, 2023
  • Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Friday, May 26th, 2023
  • Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $38 on, Friday, May 26th, 2023
  • Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023

Contributing Sources